Journal profile · Dermatology

British Journal of Dermatology

ISSN 0007-0963 · eISSN 1365-2133 · Wiley-Blackwell Publishing Ltd · ENGLAND · Monthly · Founded 1951

British Journal of Dermatology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 7.79; hybrid open access; APC about USD 4,920; median 91 days to acceptance (98 articles, last 24 months); community-reported acceptance: fairly hard; 1,107 articles in 2025; indexed in SCIE and Scopus.

Impact factor7.79Latest value listed by LetPub
CAS zoneZone 1 · Medicine2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Medicine
Review time91 daysMedian, submission to acceptance · 98 articles, last 24 months · PubMed
APCUSD 4,920Hybrid journal: charged only for open-access articles
AcceptanceFairly hardCommunity average
Articles per year1,1072025 · OpenAlex count

Scope

Aims, scope and focus

British Journal of Dermatology is published by Wiley-Blackwell Publishing Ltd and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Autoimmune Bullous Skin Diseases, Dermatology and Skin Diseases and Medicine and Dermatology Studies History, together about 27.4% of its articles. Its main subfields are Dermatology. (generated from OpenAlex topic counts and CAS ranking data)

The BJD strives to publish the highest-quality dermatological research. In so doing, the Journal aims to advance the understanding, management and treatment of skin disease in order to improve the outcomes of patient care. The main focus of the BJD (described in a position statement published in the June 2015 issue) is to publish the highest-quality research encompassing the following: Clinical trials that are registered before recruitment starts and report fully according to the CONSORT guidelines. Clinical studies that include epidemiology, qualitative research and mixed methods that conform to the STROBE and SRQR reporting guidelines. Translational research that describes basic and applied science of potential clinical relevance. Systematic reviews following the PRISMA statement, MOOSE guidelines or the ENTREQ statement. The BJD invites submissions under a broad scope of topics relevant to clinical and experimental research as described in the position statement. The Journal publishes original articles, Reviews, Clinical Guidelines, Research Letters, Perspectives, Case Reports and items of correspondence. The BJD is an official organ of the British Association of Dermatologists, but attracts contributions from dermatology researchers throughout the world. The BJD editorial board and editorial team include outstanding clinical academics, scientists and clinicians from across the globe. The circulation and readership of the BJD are equally international. The overriding criteria for publication are scientific merit, originality and interest to a multidisciplinary audience.

From the journal's Aims & Scope

Research area (LetPub): Dermatology

Editor-in-chief John McGrath LondonPublisher website

Editorial board by country: 6 in mainland China (about 3%); most named United Kingdom 55, United States 21, Germany 15, Australia 15, France 10 (184 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Autoimmune Bullous Skin DiseasesMedicine10.8%
  2. Dermatology and Skin DiseasesMedicine9.2%
  3. Medicine and Dermatology Studies HistoryMedicine7.4%
  4. Psoriasis: Treatment and PathogenesisImmunology and Microbiology6.5%
  5. Cutaneous Melanoma Detection and ManagementMedicine5.1%
  6. Cutaneous lymphoproliferative disorders researchMedicine4.8%
  7. Nail Diseases and TreatmentsMedicine4.5%
  8. Skin and Cellular Biology ResearchBiochemistry, Genetics and Molecular Biology4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorDermatologyZone 1

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorDermatologyZone 1

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorDermatologyZone 1

Top journal: yesReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

MEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website

Other: EBSCO

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
7.79LetPub ·
Impact factor (publisher) 2025
9.7Publisher website ·
Impact factor (publisher) 2023
11Publisher website ·
5-year impact factor (publisher) 2025
6Publisher website ·
CiteScore 2026-06
9.9LetPub ·
CiteScore (publisher) 2025
5Publisher website ·
SJR 2026-06
2.28LetPub ·
SNIP 2026-06
2.35LetPub ·
h-index
161LetPub ·
h-index
264OpenAlex ·
i10-index
18,862OpenAlex ·
2-year mean citedness
1.44OpenAlex ·
Self-citation rate
6.1%LetPub ·
Share of gold OA articles
44.52%LetPub ·

Volume

Articles per year
367LetPub ·
Downloads per year (publisher)
1,400,000Publisher website ·

Articles by year OpenAlex count · 42,759 in total · the current year is incomplete

YearArticlesOpen accessCitations
20261,223207140
20251,1077821,562
20241,4096433,681
20231,1506714,984
20221,1733326,859
20211,2074559,648

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with PubMed · to

91 daysMedian, submission to acceptance · P25–P75 40 days – 171 days

Acceptance to online
median 5 days (67 articles)
Submission to online
median 105 days
Sample
98 articles with submission and acceptance dates (1,217 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
2–4 weeksLetPub ·
Average acceptance (community reports)
Fairly hardLetPub ·
Submission to first decision
3 daysPublisher website ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Hybrid open accessLetPub

A subscription journal in which authors can pay to publish their article open access.

SourceAPCFee waiverLicenseObserved
OpenAlexGBP 3,731——

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Wiley-Blackwell Publishing Ltd
Country or region
ENGLAND
Language
English
Frequency
Monthly
Founded
1951
ISSN
0007-0963
Electronic ISSN
1365-2133
Society / sponsor
British Association of Dermatologists
Latest issue on the website
Volume 195, Issue 3 (September 2026)
Official links

FAQ

Frequently asked questions about British Journal of Dermatology

What CAS zone is British Journal of Dermatology in?

In the 2025 upgraded edition of the CAS Journal Ranking, British Journal of Dermatology is in Zone 1 of Medicine, and in Zone 1 of the minor category Dermatology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of British Journal of Dermatology?

The latest impact factor listed by LetPub is 7.79; CiteScore 9.9, h-index 264.

How long does peer review take at British Journal of Dermatology?

Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 91 days (interquartile range 40–171 days); authors report an average review time of 2–4 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of British Journal of Dermatology based?

Of the 184 board members whose country the journal's board page names, 6 (about 3%) are in mainland China; the countries named most often are United Kingdom (55), United States (21) and Germany (15). Counted from the institutions listed on the board page; for reference only.

Which databases index British Journal of Dermatology?

According to LetPub and DOAJ records, British Journal of Dermatology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.

Is British Journal of Dermatology open access, and what is the APC?

British Journal of Dermatology is a hybrid journal. For open-access publication: APC about USD 4,920.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .